Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | TXN | MU |
|---|---|---|
| Price | $270.31 | $1,070.14 |
| Change today | ▼ 0.85% | ▼ 0.16% |
| Market cap | $246.86B | $1.21T |
| Return, 3 months | -10.4% | +2.1% |
| Return, year to date | +58.4% | +275.2% |
| Return, 1 year | +50.4% | +562.8% |
| P/E (TTM) | 41.1 | 24.2 |
| P/B | 13.7 | 12.0 |
| P/E percentile vs own 5y | 90th | 67th |
| Dividend yield | 2.08% | 0.05% |
| Revenue growth (YoY, latest qtr) | +22.8% | +345.7% |
| Net profit growth (YoY) | +52.9% | +1,398.3% |
| Gross margin | 58.3% | 72.6% |
| Operating margin | 38.1% | 65.7% |
| Net margin | 30.9% | 55.9% |
| Return on equity | 35.0% | 66.6% |
| Analyst target vs. price | +24.3% | +46.4% |
| Analyst buy share | 62% | 97% |
| RSI (14) | 53 | 63 |
| 30-day volatility | 28.7% | 55.6% |
| Max drawdown, 1 year | -23.4% | -39.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.